BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antivirals
1
Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
1/16/2026 11:31:19 AM | Browse: 63 | Download: 221
2
Steatotic liver disease in patients with chronic hepatitis C
12/26/2025 10:27:32 AM | Browse: 54 | Download: 216
3
Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences
12/25/2025 9:13:55 AM | Browse: 71 | Download: 258
4
Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study
11/27/2025 7:53:58 AM | Browse: 46 | Download: 211
5
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals
10/27/2025 10:57:49 AM | Browse: 203 | Download: 307
6
Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis
9/25/2025 9:22:05 AM | Browse: 149 | Download: 337
7
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs
6/26/2025 7:27:55 AM | Browse: 151 | Download: 601
8
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
1/23/2024 9:31:45 AM | Browse: 300 | Download: 1292
9
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
6/28/2023 7:41:04 AM | Browse: 405 | Download: 1557
10
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
4/7/2023 5:51:03 AM | Browse: 442 | Download: 1437
11
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
2/24/2023 1:35:50 PM | Browse: 532 | Download: 1100
12
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
12/2/2022 9:49:51 AM | Browse: 625 | Download: 1595
13
Hepatitis C virus burden: Treating and educating people without prejudice
7/27/2022 1:17:38 PM | Browse: 657 | Download: 1957
14
Fibrosis regression following hepatitis C antiviral therapy
6/23/2022 2:39:01 PM | Browse: 730 | Download: 1816
15
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
6/23/2022 2:39:01 PM | Browse: 629 | Download: 1278
16
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
6/10/2022 5:40:20 AM | Browse: 751 | Download: 1682
17
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
1/11/2022 8:34:26 AM | Browse: 678 | Download: 2002
18
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
9/29/2021 11:12:00 AM | Browse: 620 | Download: 1926
19
Planning the hepatitis C virus elimination in Cyprus: A modeling study
8/18/2021 8:08:20 AM | Browse: 694 | Download: 2002
20
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
8/4/2021 7:56:20 AM | Browse: 785 | Download: 2015
21
Towards a new era of hepatitis B virus therapeutics: The pursuit of functional cure
5/27/2021 9:41:33 AM | Browse: 736 | Download: 1867
22
Viral hepatitis: A brief introduction, review of management, advances and challenges
4/28/2021 12:31:49 PM | Browse: 787 | Download: 1465
23
Genotype 3-hepatitis C virus’ last line of defense
3/17/2021 6:19:34 AM | Browse: 899 | Download: 2200
24
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
8/6/2020 9:52:06 AM | Browse: 954 | Download: 2372
25
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 1277 | Download: 2293
26
Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
4/26/2019 3:40:00 AM | Browse: 1296 | Download: 2560
27
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
10/27/2018 4:40:10 AM | Browse: 1333 | Download: 2805
28
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 926 | Download: 1685
29
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 1291 | Download: 2533
30
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1569 | Download: 2795
31
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
1/26/2018 8:09:36 AM | Browse: 1340 | Download: 2620
32
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
12/27/2017 10:31:19 AM | Browse: 1392 | Download: 2628
33
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM | Browse: 1293 | Download: 2534
34
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 1561 | Download: 3597
35
Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
6/26/2017 10:23:05 AM | Browse: 1193 | Download: 2156
36
Is it enough to eliminate hepatitis C virus to reverse the damage caused by the infection?
2/24/2017 9:02:00 AM | Browse: 1123 | Download: 1978
37
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
7/29/2016 8:32:00 PM | Browse: 1343 | Download: 2184
38
Hepatitis C virus genotypes in Myanmar
7/15/2016 3:38:00 PM | Browse: 1270 | Download: 2334
39
Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?
4/19/2016 2:32:00 PM | Browse: 1601 | Download: 2049
40
Update on hepatitis C: Direct-acting antivirals
12/4/2015 3:24:00 PM | Browse: 1341 | Download: 2364
41
Hepatitis C virus: A global view
11/18/2015 11:12:00 AM | Browse: 1594 | Download: 2397
42
Hepatitis C virus infection: Are there still specific problems with genotype 3?
11/11/2015 1:33:00 PM | Browse: 1602 | Download: 2624
43
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
10/14/2015 12:06:00 PM | Browse: 1232 | Download: 2475
44
Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments
9/9/2015 2:44:00 PM | Browse: 1377 | Download: 2476
45
New treatment strategies for hepatitis C infection
8/21/2015 1:38:00 PM | Browse: 1475 | Download: 2404
46
Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
4/19/2015 5:46:00 PM | Browse: 1766 | Download: 2144
47
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM | Browse: 1537 | Download: 2606
48
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM | Browse: 1469 | Download: 2130
49
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
8/25/2014 2:47:00 PM | Browse: 1349 | Download: 1227
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345